Loading...
 
Translate Register Log In Login with facebookLogin and Register

C-reactive protein (heart disease marker) reduced by vitamin D – meta-analysis 2014, 2019


Effect of vitamin D supplementation on the level of circulating high-sensitivity C-reactive protein: a meta-analysis of randomized controlled trials - 2014

Nutrients. 2014 Jun 10;6(6):2206-16. doi: 10.3390/nu6062206.
Chen N1, Wan Z2, Han SF3, Li BY4, Zhang ZL5, Qin LQ6.


Image Image Image

Vitamin D might elicit protective effects against cardiovascular disease by decreasing the level of circulating high-sensitivity C-reactive protein (hs-CRP), an inflammatory marker. Thus, we conducted a meta-analysis of randomized controlled trials to evaluate the association of vitamin D supplementation with circulating hs-CRP level. A systematic literature search was conducted in September 2013 (updated in February 2014) via PubMed, Web of Science, and Cochrane library to identify eligible studies. Either a fixed-effects or a random-effects model was used to calculate pooled effects. The results of the meta-analysis of 10 trials involving a total of 924 participants showed that vitamin D supplementation significantly decreased the circulating hs-CRP level by 1.08 mg/L (95% CI, -2.13, -0.03), with the evidence of heterogeneity. Subgroup analysis suggested a higher reduction of 2.21 mg/L (95% CI, -3.50, -0.92) among participants with baseline hs-CRP level ≥5 mg/L. Meta-regression analysis further revealed that baseline hs-CRP level, supplemental dose of vitamin D and intervention duration together may be attributed to the heterogeneity across studies. In summary, vitamin D supplementation is beneficial for the reduction of circulating hs-CRP. However, the result should be interpreted with caution because of the evidence of heterogeneity.

PMID: 2491869
 Download the PDF from VitaminDWiki.


Effect of Vitamin K Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis - 2019

Endocr Metab Immune Disord Drug Targets. 2019;19(1):13-25. doi: 10.2174/1871530318666180703125007.
Verma H1,2,3, Garg R1,2.

BACKGROUND:
Multiple cross sectional and longitudinal studies reported the benefits of vitamin K intake for management of cardiometabolic risk factors so as to minimize the risk of cardiovascular diseases.

OBJECTIVE: In present systematic review and meta-analysis, we aimed to evaluate the effect of vitamin K supplementation on cardiometabolic risk factors.

METHODOLOGY:
A systematic literature search of PubMed, Cochrane central, Clinicaltrials.gov, Google Scholar, Web of Science, EBSCO and Scopus databases was done from inception to November, 2017. A total of 13 trials were selected for inclusion into the present systematic review to evaluate the effect of vitamin K supplementation on cardiometabolic risk factors in healthy or in population at high risk of cardiovascular diseases.

RESULTS:
Significant beneficial effects of vitamin K supplementation were found only in case of Creactive protein (p = 0.01) and insulin sensitivity index (p <0.001), while no significant effects of vitamin K supplementation were found in case of total cholesterol (p=0.857), low density lipoprotein - cholesterol (p=0.964), high density lipoprotein - cholesterol (p=0.998), interleukin - 6 (p=0.766), systolic blood pressure (p=0.660), diastolic blood pressure (p=0.818), fasting plasma glucose (p=0.362), fasting plasma insulin (p=0.928) and homeostasis model assessment for insulin resistance (p=0.672).

CONCLUSION:
Presently available evidence are insufficient to ascertain the beneficial effects of vitamin K supplementation for the management of cardiometabolic risk factors. In order to explore the true potential of vitamin K supplementation for management of cardiometabolic diseases, large randomized placebo controlled trials are required in population with disturbed cardiometabolic profile. Present systematic review and meta-analysis is registered with PROSPERO (Registration number: CRD42018084608).


See also VitaminDWiki

See also web

  • CRP, including what decreases it Self-Hacked Dec 2017
  • CRP Wikipedia
    "CRP rises within two hours of the onset of inflammation, up to 50,000-fold, and peaks at 48 hours. Its half-life of 18 hours is constant, and therefore its level is determined by the rate of production and hence the severity of the precipitating cause. CRP is thus a marker for inflammation that can be used to screen for inflammation."
New title for this page May 2019. caused the visitor count to reset.
There have actually been 5258 visitors to this page since it was originally made

Created by admin. Last Modification: Tuesday May 21, 2019 11:38:43 GMT-0000 by admin. (Version 9)

Attached files

ID Name Comment Uploaded Size Downloads
4959 c-reactive T2.jpg admin 22 Jan, 2015 13:12 71.48 Kb 3994
4958 c-reactive F2.jpg admin 22 Jan, 2015 13:12 45.63 Kb 2187
4957 c-reactive T1.jpg admin 22 Jan, 2015 13:12 57.07 Kb 7778
4956 C-Reactive.pdf PDF 2014 admin 22 Jan, 2015 13:09 196.50 Kb 518
See any problem with this page? Report it (FINALLY WORKS)